Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaharu Oki

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMC Urology|May 12, 2026
Risk factors for recurrence following robot-assisted laparoscopic partial nephrectomy (RAPN): a single-center retrospective studyMasaharu Oki, Kojiro Ohba, Tsuyoshi Matsuda, et al.
Asian Journal of Endoscopic Surgery|February 22, 2026
Robot-Assisted Radical Nephrectomy for Renal Cell Carcinoma in a Pelvic Kidney: Case ReportDaiki Kawashima, Kojiro Ohba, Masaharu Oki, et al.
Journal of Endourology|March 31, 2025
Amount of Ipsilateral Parenchymal Volume Preserved Is a Key Determinant of Split Renal Function after Robot-Assisted Partial NephrectomyKen Kawada, Kojiro Ohba, Masaharu Oki, et al.
In Vivo (Athens, Greece)|October 30, 2025
Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell CarcinomaMasaharu Oki, Kojiro Ohba, Yuta Mukae, et al.
In Vivo (Athens, Greece)|January 2, 2026
Comparative Analysis of Immune-based Combination Therapy as First-line Treatment for Advanced Renal Cell CarcinomaYuta Mukae, Kojiro Ohba, Hiromi Nakanishi, et al.
International Cancer Conference Journal|July 8, 2025
A case of primary malignant melanoma of the ureterMasaharu Oki, Kojiro Ohba, Hiroyuki Honda, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Urology|May 12, 2026
Risk factors for recurrence following robot-assisted laparoscopic partial nephrectomy (RAPN): a single-center retrospective studyMasaharu Oki, Kojiro Ohba, Tsuyoshi Matsuda, et al.
Asian Journal of Endoscopic Surgery|February 22, 2026
Robot-Assisted Radical Nephrectomy for Renal Cell Carcinoma in a Pelvic Kidney: Case ReportDaiki Kawashima, Kojiro Ohba, Masaharu Oki, et al.
Journal of Endourology|March 31, 2025
Amount of Ipsilateral Parenchymal Volume Preserved Is a Key Determinant of Split Renal Function after Robot-Assisted Partial NephrectomyKen Kawada, Kojiro Ohba, Masaharu Oki, et al.
In Vivo (Athens, Greece)|October 30, 2025
Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell CarcinomaMasaharu Oki, Kojiro Ohba, Yuta Mukae, et al.
In Vivo (Athens, Greece)|January 2, 2026
Comparative Analysis of Immune-based Combination Therapy as First-line Treatment for Advanced Renal Cell CarcinomaYuta Mukae, Kojiro Ohba, Hiromi Nakanishi, et al.
International Cancer Conference Journal|July 8, 2025
A case of primary malignant melanoma of the ureterMasaharu Oki, Kojiro Ohba, Hiroyuki Honda, et al.
Pageof 1